Skip to main content
Laith F. Al-Rabadi
( out of 16 reviews )

Laith F. Al-Rabadi, MD

Languages spoken: English

Clinical Locations

Primary Location

University of Utah Hospital

Nephrology
50 N Medical Dr
Salt Lake City , UT 84132

Dr. Al-Rabadi finished his undergraduate and medical training at Jordan University of Science and Technology in 2007. Afterwards, he joined Edelman lab at Harvard-MIT Division of Health Sciences and Technology to study endothelial dysfunction in uremic milieu. Dr. Al-Rabdi finished his Internal Medicine training at University of Iowa in 2013 then moved on to begin nephrology training at Boston University-Boston Medical Center. He had the privilege to work with Dr. David Salant and developed special interest in Glomerular diseases. Dr. Al-Rabadi was also actively involved in teaching students and residents.

His clinical interests include different aspects of nephrology particularly glomerular diseases, transplant, and peritoneal dialysis. He is involved in several clinical research projects and literature reviews.

He established a unique collaboration with Dr. Laurence Beck at Boston Medical Center to initiate innovative projects related to membranous nephropathy (MN) pathogenesis with the goal of developing clinical and translational research and enhancing University of Utah role as a destination site for MN. Dr. Beck is a world-renowned expert and an authority in MN and published extensively on the pathogenesis and biomarkers in MN. He also established a collaboration with Dr. Bernstein and from Moran Eye Center to perform clinical studies related to Alport syndrome (AS). He has been working closely with Dr. Gregory who, along with Dr. Atkins, has collected samples, clinical information and pedigrees of 130 families with X- linked AS. They also identified over 30 families with probable autosomal recessive AS based on patterns of inheritance. He evaluates many patients with AS at the kidney and the transplant clinic.

He is motivated and committed to advance the field of glomerular diseases and Alport syndrome at the university of Utah

Board Certification

American Board of Internal Medicine (Sub: Nephrology)
American Board of Internal Medicine

Patient Rating

Patients consistently describe the physician as caring, personable, and empathetic, making them feel heard and respected. Reviewers frequently note clear, thorough explanations of conditions and treatment plans, attentive listening, and helpful follow-up instructions. Many say they trust the physician’s judgment and appreciate the thorough, reassuring care provided by the doctor and staff.

Generated via Patient Reviews

4.7 /5
( out of 16 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.


Mar 02, 2026
UNIVERSITY HOSPITAL

Great provider. I am always happy to see him.

Feb 08, 2026
UNIVERSITY HOSPITAL

Gave clear instructions and helped with medication review prior to my angiogram

Dec 08, 2025
UNIVERSITY HOSPITAL

Dr. Al-Rabadi was personable, explained everything well, answered my questions, and included me in the decisions.

Nov 16, 2025
UNIVERSITY HOSPITAL

Great Doctor to help me with my illness.

Jul 06, 2025
UNIVERSITY HOSPITAL

I like him very much so much energy on track my information was positive

Mar 17, 2025
UNIVERSITY HOSPITAL

Dr. Al-Rabadi thoroughly responded to questions and concerns I and my wife asked about my condition and adjusted my medications and testing protocol as a result. He emphasized working with other specialists at the hospital to control other systemic problems caused by my vasculitis. I was grateful when he emphasized it was important to pay attention to my symptoms, that they would be first indication of recurrence.

Mar 17, 2025
UNIVERSITY HOSPITAL

He was nice and knowledgeable

Nov 25, 2024
UH HOSPITALS AND CLINICS

Great doctor

Jan 18, 2024
UH HOSPITALS AND CLINICS

have only the best to say about Faith Al-Rabadi he has been so helpful since my sickness reared its ugly head.

Jun 29, 2023
UH HOSPITALS AND CLINICS

Me parece excelente mdico, muy cordial, atento, escucha al paciente, explica muy bien, se ve que se preocupa por el paciente.

Jun 01, 2023
UH HOSPITALS AND CLINICS

Excellent care genuinely concerned

Jun 01, 2023
UH HOSPITALS AND CLINICS

He is always personable, encouraging and optimistic. He provides clear concise information to explain my condition and current status. Unfortunately, like many excellent physicians, there are other demands for his time, and I will likely be seeing a different physician next time.

Apr 18, 2023
UH HOSPITALS AND CLINICS

HAVE ALWAY BEEN VERY GRATEFULL FOR HIM SINCE DAY ONE HE IS VERY CARING AND HELPFULL

Apr 15, 2023
UH HOSPITALS AND CLINICS

I feel confident that he is giving me the best care available for my kidney condition and have every confidence in him as a doctor

Nov 25, 2022
University Hospital

Good

Nov 23, 2022
University Hospital

They made me feel like I matter. That means a lot to me

Nov 18, 2022
University Hospital

I adore Dr. Al Ribaldi he is very caring, explains everything well and even said he'd see me on emergency notice.

Aug 19, 2022
UH HOSPITALS AND CLINICS

Dr. Al Rabadi is wonderful! I trust him completely and his staff always makes us feel comfortable and they are so willing to help with anything we need

Jul 29, 2022
UH HOSPITALS AND CLINICS

Good

Feb 19, 2022
UH HOSPITALS AND CLINICS

Great experience

Feb 18, 2022
UH HOSPITALS AND CLINICS

Very personable

Feb 08, 2022
UH HOSPITALS AND CLINICS

Routine visit.

Feb 04, 2022
UH HOSPITALS AND CLINICS

I just can't enough good things abt dr Al Rabidi. He is an amazing and compassionate physician.

Jan 31, 2022
UH HOSPITALS AND CLINICS

My Drs has been great. I have not met a doctor that doesn't care. All the Drs I've seen so far have been so caring and helpful. I owe them so much more than my life. I know they care and love each patient. A Dr who has empathy towards their patients is a good Dr. One that takes their time to help you and make sure you're going to be taken care of. I couldn't ask for better Drs. Thank you all! Please give them raises so they can continue to work as my Drs for many years to come!

Jan 27, 2022
UH HOSPITALS AND CLINICS

Excellent as always

Jan 19, 2022
UH HOSPITALS AND CLINICS

The doctors and all of the staff are always great with answering questions and making sure I understand all options for treatment.

Dec 10, 2021
UH HOSPITALS AND CLINICS

I love Dr al Rabadi. He's the best

Oct 22, 2021
UH HOSPITALS AND CLINICS

Interview seem rushed. Under the circumstances of Covid-19 and the pressure put on medical personal, the rushed interview is understandable.

Oct 08, 2021
UH HOSPITALS AND CLINICS

Exceptional attention and care Quick but complete and reassuring

Oct 02, 2021
UH HOSPITALS AND CLINICS

Dr. Was a bit rushed because of another unscheduled patient, but still managed to be very attentive.

Sep 16, 2021
UH HOSPITALS AND CLINICS

Dr. Was very sweet with my mother.

Jul 18, 2021
UH HOSPITALS AND CLINICS

Excellent, thoughtful, and considerate interaction with me and my wife. Very nice experience.

Jun 08, 2021
UH HOSPITALS AND CLINICS

Good

May 16, 2021
UH HOSPITALS AND CLINICS

superb experience

May 03, 2021
UH HOSPITALS AND CLINICS

Very optimistic, encouraging, positive attitude and concerned about my health.

Mar 04, 2021
UH HOSPITALS AND CLINICS

listened to my concerns and advocated foe me to go home to my own space for healing

Dec 26, 2020
UH HOSPITALS AND CLINICS

The best I ever experienced

Nov 28, 2020
UH HOSPITALS AND CLINICS

Dr Al-Rabadi is one of the best doctors

Aug 27, 2020
UH HOSPITALS AND CLINICS

DR LAITH SPENT A LONG TIME WITH US, EXPLAINING HIS CONCERNS, LISTENING TO OUR CONCERNS, EXPLAINING RECOMENDATIONS AND FOLLOW UP REQUIREMENTS FOR MARGI...

Aug 22, 2020
UH HOSPITALS AND CLINICS

Basically very brief in-person visit to review results of lab work and check blood pressure.

Aug 10, 2020
UH HOSPITALS AND CLINICS

He is always awesome! He is so cheerful, and he makes you feel that he really does care.

Jul 22, 2020
UH HOSPITALS AND CLINICS

VERY GOOD

Apr 27, 2020
UH HOSPITALS AND CLINICS

Just a routine visit. Much better in person.

Feb 09, 2020
UH HOSPITALS AND CLINICS

Dr AlRabadi is very thorough. Always a great experience.


Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

Dr. Al-Rabadi finished his undergraduate and medical training at Jordan University of Science and Technology in 2007. Afterwards, he joined Edelman lab at Harvard-MIT Division of Health Sciences and Technology to study endothelial dysfunction in uremic milieu. Dr. Al-Rabdi finished his Internal Medicine training at University of Iowa in 2013 then moved on to begin nephrology training at Boston University-Boston Medical Center. He had the privilege to work with Dr. David Salant and developed special interest in Glomerular diseases. Dr. Al-Rabadi was also actively involved in teaching students and residents.

His clinical interests include different aspects of nephrology particularly glomerular diseases, transplant, and peritoneal dialysis. He is involved in several clinical research projects and literature reviews.

He established a unique collaboration with Dr. Laurence Beck at Boston Medical Center to initiate innovative projects related to membranous nephropathy (MN) pathogenesis with the goal of developing clinical and translational research and enhancing University of Utah role as a destination site for MN. Dr. Beck is a world-renowned expert and an authority in MN and published extensively on the pathogenesis and biomarkers in MN. He also established a collaboration with Dr. Bernstein and from Moran Eye Center to perform clinical studies related to Alport syndrome (AS). He has been working closely with Dr. Gregory who, along with Dr. Atkins, has collected samples, clinical information and pedigrees of 130 families with X- linked AS. They also identified over 30 families with probable autosomal recessive AS based on patterns of inheritance. He evaluates many patients with AS at the kidney and the transplant clinic.

He is motivated and committed to advance the field of glomerular diseases and Alport syndrome at the university of Utah

Board Certification and Academic Information

Academic Departments Internal Medicine -Associate Professor (Clinical)
Pathology -Adjunct Associate Professor
Academic Divisions Nephrology & Hypertension
Board Certification
American Board of Internal Medicine (Sub: Nephrology)
American Board of Internal Medicine

Education history

Professional Medical Medicine - Jordan University of Science and Technology M.B.B.S.
Internship General Medicine - Ministry of Health Transitional Internship
Internship General Surgery - King Abdullah University Hospital Intern
Internship Internal Medicine - University of Iowa Hospitals and Clinics Intern
Residency Internal Medicine - University of Iowa Hospitals and Clinics Resident
Fellowship Nephrology - Boston Medical Center, Boston University Fellow

Selected Publications

Journal Article

  1. Al-Rabadi LF, Beck LH J (2023). Neuronal Proteins as Antigenic Targets in Membranous Nephropathy. Nephron, 147(8), 451-457.
  2. Tiffany N. Caza1¿, Laith F. Al-Rabadi2¿ and Laurence H. Beck J (2021). How Times Have Changed! A Cornucopia of Antigens for Membranous Nephropathy . Frontiers in immunology,
  3. Cook MM, Al Rabadi L, Kaempf AJ, Saraceni MM, Savin MA, Mitri Z (2021). Everolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor Therapy. The oncologist, 26(2), 101-106.
  4. Savige J, Storey H, Watson E, Hertz JM, Deltas C, Renieri A, Mari F, Hilbert P, Plevova P, Byers P, Cerkauskaite A, Gregory M, Cerkauskiene R, Ljubanovic DG, Becherucci F, Errichiello C, Massella L, Aiello V, Lennon R, Hopkinson L, Koziell A, Lungu A, Rothe HM, Hoefele J, Zacchia M, Martic TN, Gupta A, van Eerde A, Gear S, Landini S, Palazzo V, Al-Rabadi L, Claes K, Corveleyn A, Van Hoof E, van Geel M, Williams M, Ashton E, Belge H, Ars E, Bierzynska A, Gangemi C, Lipska-Zi'tkiewicz B (2021). Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria. European journal of human genetics, 29(8), 1186-1197.
  5. Al-Rabadi LF, Caza T, Trivin-Avillach C, Rodan AR, Andeen N, Hayashi N, Williams B, Revelo MP, Clayton F, Abraham J, Lin E, Liou W, Zou CJ, Ramkumar N, Cummins T, Wilkey DW, Kawalit I, Herzog C, Storey A, Edmondson R, Sjoberg R, Yang T, Chien J, Merchant M, Arthur J, Klein J, Larsen C, Beck LH J (2021). Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous Nephropathy. Journal of the American Society of Nephrology, 32(7), 1666-1681.
  6. Al-Rabadi L, Box T, Singhania G, Al-Marji C, Agarwal A, Hall I, Gordon CE, Tran (2018). Rationale for treatment of hepatitis C virus infection in end-stage renal disease patients who are not kidney transplant candidates. Hemodialysis international. International Symposium on Home Hemodialysis, 22 Suppl 1, S45-S52.
  7. Khalighi MA, Al-Rabadi L, Chalasani M, Smith M, Kakani S, Revelo MP, Meehan S (2018). Staphylococcal Infection-Related Glomerulonephritis With Cryoglobulinemic Features. Kidney international reports, 3(5), 1128-1134.
  8. Shivanna S, Kolandaivelu K, Shashar M, Belghasim M, Al-Rabadi L, Balcells M, Zhang A, Weinberg J, Francis J, Pollastri MP, Edelman ER, Sherr DH, Chitalia VC (2016). The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia. J Am Soc Nephrol, 27(1), 189-201.
  9. Al-Rabadi L, Francis JM, Henderson J, Ghai (2015). Proliferative glomerulonephritis with monoclonal immunoglobulin in renal allografts. Clinical kidney journal, 8(6), 722-8.
  10. Chitalia VC, Murikipudi S, Indolfi L, Rabadi L, Valdez R, Franses JW, Edelman E (2011). Matrix-embedded endothelial cells are protected from the uremic milieu. Nephrology, dialysis, transplantation, 26(12), 3858-65.

Review

  1. Caza T, Wijewardena C, Al-Rabadi L, Perl (2022). Cell type-specific mechanistic target of rapamycin-dependent distortion of autophagy pathways in lupus nephritis. Translational research,

Book Chapter

  1. Al-Rabadi (2019). Renal and Metabolic Disorders Related to Alcohol and Other Drug Use.

Case Report

  1. Bansal S, Singhania N, Nukala CM, Singh AK, Al-Rabadi (2021). Histoplasma stomatitis unveiled: Not all opportunistic infections get better after initiation of antiretroviral therapy. Clinical case reports, 9(3), 1466-1468.
  2. Singhania N, Singhania G, Al-Rabadi (2020). Acquired Reactive Perforating Collagenosis. Clinical and experimental nephrology, 24(11), 1086-1087.
  3. Singhania N, Al-Odat R, Singh AK, Al-Rabadi (2020). Intestinal necrosis after co-administration of sodium polystyrene sulfonate and activated charcoal. Clinical case reports, 8(4), 722-724.
  4. Al-Rabadi L, Quillen K, Shashar M, Al Marji C, Jaberi A, Chitalia V, Henderson J, Salant D, Beck LH J (2017). Concurrent Presentation of Thrombotic Thrombocytopenic Purpura and Membranous Nephropathy. Kidney international reports, 3(2), 476-481.
  5. Al-Rabadi L, Ayalon R, Bonegio RG, Ballard JE, Fujii AM, Henderson JM, Salant DJ, Beck LH Jr (2016). Pregnancy in a Patient With Primary Membranous Nephropathy and Circulating Anti-PLA2R Antibodies: A Case Report. Am J Kidney Dis, 67(5), 775-8.
  6. Aburizik A, Singh S, Al-Rabadi L, Blosser (2014). Mistaken identity: normotensive scleroderma renal crisis.LID - 10.1136/bcr-2013-202566 [doi]LID - bcr2013202566 [pii]. BMJ case reports, 2014,

Editorial

  1. Caza TN, Al-Rabadi L (2022). What Can Mercury Teach Us About Membranous Nephropathy and Minimal Change Disease?. Kidney international reports, 7(6), 1157-1160.

Abstract

  1. Al-Odat R, Al-Rabadi L, Blosser C, Francis (2014). Hypermagnesemia-induced hypothermia in a pregnant patient.
  2. Al-Rabadi LF, Al-odat RT, Blosser C (2012). Tacrolimus-Induced Thrombotic Microangiopathy Post Allogeneic Stem Cell Transplant. 23(Abstract Issue), PUB36, 902A.
  3. Erinle AO, Al-Rabadi LF, Sarker A, Gamilla-Crudo AK, Ishihara K, Beach (2008). Seronegative Anti-GBM Disease; Clinical Dilemma in Management. 19(Abstract Issue), 989A-990A.

Other

  1. Savige J, Storey H, Watson E, Hertz JM, Deltas C, Renieri A, Mari F, Hilbert P, Plevova P, Byers P, Cerkauskaite A, Gregory M, Cerkauskiene R, Ljubanovic DG, Becherucci F, Errichiello C, Massella L, Aiello V, Lennon R, Hopkinson L, Koziell A, Lungu A, Rothe HM, Hoefele J, Zacchia M, Martic TN, Gupta A, van Eerde A, Gear S, Landini S, Palazzo V, Al-Rabadi L, Claes K, Corveleyn A, Van Hoof E, van Geel M, Williams M, Ashton E, Belge H, Ars E, Bierzynska A, Gangemi C, Lipska-Zi'tkiewicz B (2023). Correction: Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria. European journal of human genetics,
  2. Savige J, Lipska-Zietkiewicz BS, Watson E, Hertz JM, Deltas C, Mari F, Hilbert P, Plevova P, Byers P, Cerkauskaite A, Gregory M, Cerkauskiene R, Ljubanovic DG, Becherucci F, Errichiello C, Massella L, Aiello V, Lennon R, Hopkinson L, Koziell A, Lungu A, Rothe HM, Hoefele J, Zacchia M, Martic TN, Gupta A, van Eerde A, Gear S, Landini S, Palazzo V, Al-Rabadi L, Claes K, Corveleyn A, Van Hoof E, van Geel M, Williams M, Ashton E, Belge H, Ars E, Bierzynska A, Gangemi C, Renieri A, Storey H, Flinter (2022). Guidelines for Genetic Testing and Management of Alport Syndrome. Clinical journal of the American Society of Nephrology, 17(1), 143-154.
  3. May RM, Cassol C, Hannoudi A, Larsen CP, Lerma EV, Haun RS, Braga JR, Hassen SI, Wilson J, VanBeek C, Vankalakunti M, Barnum L, Walker PD, Bourne TD, Messias NC, Ambruzs JM, Boils CL, Sharma SS, Cossey LN, Baxi PV, Palmer M, Zuckerman JE, Walavalkar V, Urisman A, Gallan AJ, Al-Rabadi LF, Rodby R, Luyckx V, Espino G, Santhana-Krishnan S, Alper B, Lam SG, Hannoudi GN, Matthew D, Belz M, Singer G, Kunaparaju S, Price D, Chawla S, Rondla C, Abdalla MA, Britton ML, Paul S, Ranjit U, Bichu P, Williamson SR, Sharma Y, Gaspert A, Grosse P, Meyer I, Vasudev B, El Kassem M, Velez JCQ, Caza T (2021). A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19). Kidney international, 100(6), 1303-1315.
  4. Huang Z, Liu S, Tang A, Al-Rabadi L, Henkemeyer M, Mimche PN, Huang (2021). Key role for EphB2 receptor in kidney fibrosis. Clinical science (London, England, 135(17), 2127-2142.
  5. Lazaro-Guevara J, Fierro-Morales J, Wright AH, Gunville R, Simeone C, Frodsham SG, Pezzolesi MH, Zaffino CA, Al-Rabadi L, Ramkumar N, Pezzolesi M (2021). Targeted Next-Generation Sequencing Identifies Pathogenic Variants in Diabetic Kidney Disease. American journal of nephrology, 52(3), 239-249.